Launching DTC models requires navigating regulatory and licensing rules.
Alan Arville, JD
Advertisement
Articles by Alan Arville, JD
Advertisement
Latest Updated Articles
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer ProgramsPublished: October 10th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
3
Join Us Tonight: Inside Trump’s Drug Price Plan
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
